A Devergié

8.3k total citations · 1 hit paper
123 papers, 5.8k citations indexed

About

A Devergié is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, A Devergié has authored 123 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hematology, 32 papers in Oncology and 23 papers in Genetics. Recurrent topics in A Devergié's work include Hematopoietic Stem Cell Transplantation (82 papers), Polyomavirus and related diseases (18 papers) and Transplantation: Methods and Outcomes (12 papers). A Devergié is often cited by papers focused on Hematopoietic Stem Cell Transplantation (82 papers), Polyomavirus and related diseases (18 papers) and Transplantation: Methods and Outcomes (12 papers). A Devergié collaborates with scholars based in France, United States and United Kingdom. A Devergié's co-authors include Éliane Gluckman, Gèrard Socié, E Gluckman, Hélène Espérou, Dominique Thierry, Patricia Ribaud, Arleen D. Auerbach, Gérard Socié, P Lehn and HE Broxmeyer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

A Devergié

119 papers receiving 5.6k citations

Hit Papers

Hematopoietic Reconstitution in a Patient with Fanconi's ... 1989 2026 2001 2013 1989 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Devergié France 40 4.1k 1.5k 1.3k 869 841 123 5.8k
K Atkinson Australia 41 4.7k 1.2× 1.5k 1.0× 1.4k 1.0× 2.0k 2.3× 901 1.1× 158 6.7k
Hélène Espérou France 36 2.9k 0.7× 1.1k 0.7× 843 0.6× 1.0k 1.2× 925 1.1× 90 4.6k
Giorgio Dini Italy 39 3.1k 0.7× 2.3k 1.6× 1.3k 1.0× 1.2k 1.4× 1.0k 1.2× 153 6.5k
George E. Sale United States 37 4.5k 1.1× 1.1k 0.8× 1.7k 1.3× 2.1k 2.4× 935 1.1× 97 7.4k
Clift Ra United States 40 6.0k 1.5× 1.6k 1.1× 1.7k 1.3× 1.5k 1.7× 1.2k 1.4× 100 7.2k
Rainer Schwerdtfeger Germany 43 4.3k 1.1× 1.2k 0.8× 1.4k 1.0× 1.3k 1.5× 1.2k 1.4× 126 6.0k
JE Sanders United States 43 5.8k 1.4× 1.1k 0.8× 1.7k 1.3× 1.6k 1.8× 1.8k 2.2× 100 7.2k
Peter A. McSweeney United States 44 3.9k 1.0× 1.0k 0.7× 1.6k 1.2× 1.7k 2.0× 821 1.0× 143 6.3k
Francesca Gualandi Italy 40 3.2k 0.8× 2.1k 1.4× 1.6k 1.2× 1.5k 1.7× 700 0.8× 129 6.1k
Robert P. Witherspoon United States 48 5.7k 1.4× 1.2k 0.8× 2.1k 1.6× 2.3k 2.7× 1.2k 1.5× 104 8.0k

Countries citing papers authored by A Devergié

Since Specialization
Citations

This map shows the geographic impact of A Devergié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Devergié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Devergié more than expected).

Fields of papers citing papers by A Devergié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Devergié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Devergié. The network helps show where A Devergié may publish in the future.

Co-authorship network of co-authors of A Devergié

This figure shows the co-authorship network connecting the top 25 collaborators of A Devergié. A scholar is included among the top collaborators of A Devergié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Devergié. A Devergié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bittencourt, Henrique, Vanderson Rocha, Irina Ionescu, et al.. (2005). Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders. Bone Marrow Transplantation. 36(5). 431–435. 29 indexed citations
3.
Rousselot, P, H Rochant, Ali G. Turhan, et al.. (2000). Mise au point sur la leucémie myéloïde chronique. 6(2). 129–140.
4.
Parquet, Nathalie, O Reigneau, Henri Humbert, et al.. (2000). New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients. Bone Marrow Transplantation. 25(9). 965–968. 35 indexed citations
5.
Yakoub‐Agha, Ibrahim, Gandhi Damaj, Laurent Garderet, et al.. (2000). Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia. Bone Marrow Transplantation. 26(2). 215–218. 5 indexed citations
6.
Brauner, Raja, Luís Adan, J.C. Souberbielle, et al.. (1997). Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. The Journal of Pediatrics. 130(5). 785–792. 65 indexed citations
7.
Pigneux, Arnaud, A Devergié, E Archimbaud, et al.. (1995). Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de Moelle.. PubMed. 15(6). 819–24. 9 indexed citations
9.
Devergié, A, André Baruchel, Patricia Ribaud, et al.. (1995). Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.. PubMed. 15(6). 943–7. 23 indexed citations
10.
Bertheau, P, Antoine Hadengue, Dominique Cazals‐Hatem, et al.. (1995). Chronic cholestasis in patients after allogeneic bone marrow transplantation: several diseases are often associated.. PubMed. 16(2). 261–5. 3 indexed citations
11.
Socié, Gèrard, L. Sedel, J Frija, et al.. (1994). Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. British Journal of Haematology. 86(3). 624–628. 63 indexed citations
12.
Heudes, Didier, et al.. (1993). Towards an objective prognostic index of acute graft-versus-host disease.. PubMed. 5(5). 289–97. 1 indexed citations
13.
Gluckman, Éliane, R Traineau, A Devergié, H Espérou-Bourdeau, & Ivan Hirsch. (1992). Prevention and treatment of CMV infection after allogeneic bone marrow transplant. Annals of Hematology. 64(S1). A158–A161. 8 indexed citations
14.
Socié, Gèrard, Judith Landman, Éliane Gluckman, et al.. (1992). Short‐term study of chimaerism after bone marrow transplantation for severe aplastic anaemia. British Journal of Haematology. 80(3). 391–398. 19 indexed citations
16.
Socié, Gèrard, M. Henry‐Amar, J M Cosset, et al.. (1991). Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia [see comments]. Blood. 78(2). 277–279. 120 indexed citations
17.
Fontoura, Manuel, Raja Brauner, R Rappaport, et al.. (1988). GROWTH AND ENDOCRINE FUNCTION AFTER BONE MARROW TRANSPLANTATION (BMT) WITH OR WITHOUT TOTAL BODY IRRADIATION (TBI). Pediatric Research. 23(1). 111–111. 1 indexed citations
18.
Bellucci, Sylvia, A Devergié, Éliane Gluckman, et al.. (1985). Complete correction of Glanzmann's thrombasthenia by allogeneic bone‐marrow transplantation. British Journal of Haematology. 59(4). 635–641. 47 indexed citations
19.
Gluckman, Éliane, A Devergié, Xinyu Zhao, et al.. (1984). Utilisation de l'acyclovir dans la prévention des infections herpétiques après greffe de moelle osseuse allogénique. Revue Franç aise de Transfusion et Immuno-hé matologie. 27(3). 391–396. 3 indexed citations
20.
Gluckman, Éliane, William Arcese, A Devergié, & M Boiron. (1981). Cyclosporin-A prophylactic treatment of graft-versus-host disease in human allogeneic bone marrow transplantation: preliminary results.. PubMed. 13(1 Pt 1). 368–70. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026